Frontlight ResearchEarly access
Atrial fibrillation trials in Argentina
3 of 5 trials · From ClinicalTrials.gov, checked 18 November 2026. Ask the study team whether a trial fits you.
- Phase 2Taking peopleSafety in Adult Participants With Atrial Fibrillation Who Are Treated With Anticoagulation
- Where
- Buenos Aires, Ciudad Autonoma de Buenos Aires, Córdoba, Ramos Mejía, Rosario, Santa Fe, Temperley
- Age
- 18 years and over
- People
- 1,200 worldwide
- Run by
- Regeneron Pharmaceuticals
See details and how to joinNCT07175428 - Phase 3Taking peopleStudy to evaLuate the effIcacy and Safety of abeLacimab in High-risk Patients With Atrial Fibrillation Who Have Been Deemed Unsuitable for Oral antiCoagulation (LILAC-TIMI 76)
- Where
- Bahía Blanca, Buenos Aires, Ciudad Autónoma Buenos Aires, Ciudad Autónoma de Buenos Aire, Ciudadela, Córdoba, Coronel Suárez, Corrientes, La Plata, Quilmes, Ramos Mejía, Salta, San Luis, San Martin, San Miguel de Tucumán, San Nicolás, Temperley, Villa María
- Age
- 65 years and over
- People
- 2,500 worldwide
- Run by
- Anthos Therapeutics, Inc.
See details and how to joinNCT05712200 · EU 2023-503224-66-00 - Phase 4Taking peopleAnticoagulation for Stroke Prevention In Patients With Recent Episodes of Atrial Fibrillation Occurring Transiently With Stress
- Where
- Chivilcoy, Coronel Suárez, Rosario, San Miguel de Tucumán, Santa Fe
- Age
- 55 years and over
- People
- 2,270 worldwide
- Run by
- Population Health Research Institute
See details and how to joinNCT03968393 · EU 2023-509142-35-00